Automated External Defibrillator Market worth $930 Million By 2017

Thursday 6 June 2013, Amsterdam

The "Automated External Defibrillator Market (Trends, Technology and End-Users) (2012-2017)"analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Japan, Asia, and Rest of the World.

This report studies the global automated external defibrillator market, with forecast to 2017.

The automated external defibrillator (AED) market is divided into twosegments, namely,semi-automated and fully automated. Bothtypes are available at nearly same cost and are equally efficient in saving lives, although theyfunction differently.

The global automated external defibrillator market was worth $616million in the year 2012. The market will grow at a healthy pace in the next five years due to the increasing incidence of cardiovascular disease, growing awareness about the lifesaving potential of AED, increasing installation of public access AEDs, and technological advancements. Strategic collaborations, untapped emerging markets and home defibrillators represent vast opportunities for major shareholders of this market. However, frequent product recalls from various manufacturers and intense competition in mature markets will restrict the growth of the market,to some extent.

North America is the largest market for AED, followed by Japan and Europe. Public access defibrillation programs have stimulated the growth of AED market in these regions. The European and Asian marketsare expected to witness double-digit growth over the next five years, owing to the increasing installation of public access AEDs.

Key players in the AED market are Philips Healthcare (The Netherlands), Cardiac Science (U.S.), ZOLL Medical Corporation (U.S.), Nihon Kohden (Japan), Physio-Control (U.S.), Defibtech (U.S.), HeartSine Technologies (U.S.), and Schiller (Switzerland).